Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ) announced earnings for its full year that Increased, from the same period last year
The company's bottom line totaled RMB449.64 million, or RMB0.45 per share. This compares with RMB397.17 million, or RMB0.40 per share, last year.
The company's revenue for the period fell 6.0% to RMB3.758 billion from RMB4.000 billion last year.
Zhejiang Xianju Pharmaceutical Co.,Ltd. earnings at a glance (GAAP) :
-Earnings: RMB449.64 Mln. vs. RMB397.17 Mln. last year.-EPS: RMB0.45 vs. RMB0.40 last year.-Revenue: RMB3.758 Bln vs. RMB4.000 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.